• No se han encontrado resultados

TítuloTreatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology

N/A
N/A
Protected

Academic year: 2020

Share "TítuloTreatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology"

Copied!
23
0
0

Texto completo

Loading

Figure

Figure  1.  Diagnosis–treatment  algorithm.  CPET,  cardiopulmonary  exercise  test;  PVO 2 ,  peak  oxygen  consumption;  LV,  left  ventricle; RV, right ventricle

Referencias

Documento similar

The main hypothesis of the SPHERE-HF ( b 3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure) trial is that maintenance treatment with

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart

The incidence and prevalence of these diseases are increasingly globally, and although more research is needed to elucidate its role in pathologies such as atrial

The Dwellers in the Garden of Allah 109... The Dwellers in the Garden of Allah

Patients with IE in the latter period of the study were older, more likely to have higher Charlson index, hypertension, heart failure, chronic obstructive pulmonary disease,

The aim of this study is to evaluate the effectiveness of a new exercise program for people with heart failure (EFICAR), additional to the recommended optimal treatment in primary

We thus can suggest that NRG1-ERBB2,4 signalling during compaction regulates myocardial patterning and metabolism, compact myocardium thickness, and coronary

AAV9-CnAβ1 decreases the expression of genes associated with heart failure and fibrosis in the remote myocardium post MI – AAV9-CnAβ1 administration at a dose of 3.5e10 VP,